ChemoCentryx Inc reports results for the quarter ended in March - Earnings Summary

Churchill Capital XI

30/04/2021 03:12

* ChemoCentryx Inc  CCXI.OQ  reported a quarterly adjusted loss
of 43 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 40 cents per share.
* Revenue rose 72.3% to $10.35 million from a year ago​; 
analysts expected $7.93 million.
* ChemoCentryx Inc's reported EPS for the quarter was a loss
of 43 cents​.
* The mean earnings estimate of analysts had risen by about 1.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* ChemoCentryx Inc shares had fallen by 10.2% this quarter and
lost 25.7% so far this year.
* The company reported a quarterly loss of $29.71 million.
* Wall Street's median 12-month price target for ChemoCentryx
Inc is $84.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated April 30 at 02:12 a.m. GMT.
​All figures in US Dollars.​